SENORES PHARMACEUTICALS
Back to Income Statement
|
SENORES PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Sales | ₹398 Cr | ₹215 Cr | ₹35 Cr | ₹14 Cr |
What is the latest Revenue of SENORES PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹398 Cr |
| Mar2024 | ₹215 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹14 Cr |
How is Revenue of SENORES PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹398 Cr | 85.65 | |
| Mar2024 | ₹215 Cr | 507.07 | |
| Mar2023 | ₹35 Cr | 149.38 | |
| Mar2022 | ₹14 Cr | - | |
Compare Revenue of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹7,128.7 Cr | 4.8% | 10.5% | 126.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 4.8% |
10.5% |
126.7% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses